Avita Medical Inc (RCEL) - News Archive

In a significant step towards enhancing patient care for burn injuries, AVITA Medical has received positive endorsement from the Medical Services Advisory Committee (MSAC) in Australia for its groundbreaking RECELL syst...

Presented by CSIMarket.com In a groundbreaking presentation at the BBA 2025, AVITA Medical showcased the largest real-world analysis of its RECELL system, highlighting its potential to revolutionize inpatient burn care....

In a pivotal move that underscores its commitment to advancing medical technologies, AVITA Medical has announced the U.S. launch of Cohealyx, a revolutionary collagen-based dermal matrix specifically engineered to enhan...

In a significant turn of events for AVITA Medical (NASDAQ: AVTA), the company has recently announced the FDA’s 510(k) clearance for its innovative product, Cohealyx. This regulatory approval expands AVITA s addressable...

AVITA Medical Expands RECELL Product Platform to Australia and New Zealand through Exclusive Distribution Agreement In a significant strategic move aimed at broadening its geographical footprint, AVITA Medical has annou...

Avita Medical Inc. a biotech firm specializing in regenerative medicine, has released its financial results for the third quarter, revealing a mixed bag of outcomes that has left investors concerned about its trajectory...

In a significant move aimed at enhancing wound care solutions, AVITA Medical has announced the expansion of its product portfolio through an exclusive development and distribution agreement with Regenity Biosciences. Th...

In a groundbreaking development, AVITA Medical, a renowned regenerative medicine company, recently achieved a significant milestone by successfully treating their first patient using the FDA-approved RECELL GO System. T...